Supplementary Figure S1 from Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial

Supplemental Figure 1. Continuous risk curves of BCI and BCIN+ for overall 10-year DR in patients who did not receive adjuvant chemotherapy. A: risk of overall 10-year DR as a function of continuous BCI for N0 patients (N=1196); B: risk of overall 10-year DR as a function of continuous BCIN+ for N1 patients (N=1234); C: risk of overall 10-year DR as a function of continuous BCI for N0 HER2- patients (N=978); D: risk of overall 10-year DR as a function of continuous BCIN+ for N1 HER2- patients (N=1067).